James M. Mock - 05 Jan 2026 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Financial Officer
Signature: /s/ James Dillon, As Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 05 Jan 2026
Net transactions value: -$24,071
Form type: 4
Filing time: 06 Jan 2026, 16:36:50 UTC
Previous filing: 08 Dec 2025
Next filing: 13 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mock James M	Chief Financial Officer	C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE	/s/ James Dillon, As Attorney-in-Fact	06 Jan 2026	0001736359

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+1,452	+3.4%		44,652	05 Jan 2026	Direct	F1
transaction	MRNA	Common Stock	Tax liability	$24,071	-780	-1.7%	$30.86	43,872	05 Jan 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-1,452	-25%	$0.000000	4,359	05 Jan 2026	Common Stock	1,452		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3	25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.